All Type of News


1,660 Korean people deliver signatures for ‘Opposition to Tylenol’ to MOHW

The pharmaceutical society and people delivered signatures to immediately suspend convenient stores to sell Tylenols and suggested the ‘National Task on Public Late-Night Pharmacy.’ The Society for the Future of Phar...

Kolon Life Science’s Invossa Inj to achieve 1,500 procedures

Kolon Life Science(CEO Woo-Seok Lee) announced they acquired approval of Invossa on July 2017, started to sell the product on November and achieved more than 1,500 procedures to July 2018 for 9 months. According to t...

What are major issues for the 2nd year half in Korean drug market?

Korea must be careful regarding exporting pharmaceutical products this year due to various aspects such as nullification of the Ecuadorian drug agreement and Indonesian ‘Protectionism.’ The KOTRA(Korea Trade-Investme...

Celltrion acquires Australian approval of trastuzumab biosimilar ‘Herzuma’

Celltrion recently announced they acquired sales approval of therapeutic antibody biosimilar for breast cancer and stomach cancer ‘Herzuma(generic name: trastuzumab)’ from the Australian Therapeutic Goods Administrati...

Upper for Lipiodol decided at KRW 190 thousand with obligation of stable supply

Lipiodol, which has recently been suspended in supply, has come to the final decision at the Health Insurance Policy Deliberation Committee after the drug price negotiation with the National Health Insurance Service(N...

Dong Wha Pharm’s first step to enter global market

Dong Wha Pharm, the oldest Korean pharmaceutical company with 121 years of history, have been active in expanding its new drug business to other countries, strengthen its open innovation profile and starting more new ...

1 pharmacy for approximately 2,300 people in Korea

Among the 18 Korean cities and provinces, regional areas with the highest drug accessibility were reportedly Seoul, Daegu, Daejeon and Jeonbuk. Yakup Shinmoon(www.yakup.com) analyzed population and the number of phar...

70 Korean pharmas including Yuhan Corporation participate in ‘CPhI Worldwide 2018’

About 70 Korean pharmaceutical companies will participated in the world’s largest pharmaceutical conference held in Madrid, Spain on the coming 10th ‘CPhI Worldwide 2018’ and start to pioneer new exporting markets. T...

Daewoong finishes resubmitting documents for Nabota to FDA

Daewoong Pharmaceutical’s botulinum toxin ‘Nabota’ has taken the last step to enter the U.S. market. Daewoong Pharmaceutical(CEO Seung-Ho Jeon) announced on the 2nd that they turned in revised documents to the U.S. F...

KPA, “We’ve never asked KRW 4.5 million for operating public late-night pharmacies”

The pharmaceutical association refuted that it was not true they requested KRW 4.5 million for public late-night pharmacy. The Korea Pharmaceutical Association(KPA) announced in a refutation statement on the 4th that...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.